header
Image from OpenLibrary

Glypican 3 expression in urothelial carcinoma : Histopathological & immunohistochemical study / Sara Mohamad Aboufandoud Mohamad ; Supervised Solafa Amin Abdalaziz , Samia Mohamad Gabal , Wael Moustafa Mohamad

By: Contributor(s): Material type: TextTextLanguage: English Publication details: Cairo : Sara Mohamad Aboufandoud Mohamad , 2018Description: 120 P. : charts , facsimiles ; 25cmOther title:
  • التعبيرعن جليبيكان ٣ فى سرطان الظهارة البولية: دراسة هستوباثولوجية و مناعية نسيجية كيميائية [Added title page title]
Subject(s): Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Pathology Summary: Background: Glypican 3 (GPC3) is an oncofetal protein, playing a role in cell regulation during fetal development, via Wingless/Integration (Wnt) signaling pathway. GPC3 immunohistochemical expression was detected in several tumors, most obvious in hepatocellular carcinoma. GPC3 antibody is under clinical trials for therapeutic approach of hepatocellular carcinoma. Aim of Work: Assessment of immunohistochemical (IHC) expression of GPC3 in urothelial carcinoma (UC), to detect its possible role in stimulating Wnt signaling which is supposed to be partially responsible for urothelial carcinogenesis.Methods: This study consisted of 125 cases of urothelial carcinoma, included 90 cases of radical cystectomies with high grade UC & 35 cases of transurethral resection of bladder tumor (TURT) with low grade UC. IHC was carried out using GPC3 monoclonal antibody. Positive expression was considered when < 10% of tumor cells showed cytoplasmic &/or membranous GPC3 expression, regardless of the intensity. Results: GPC3 expression was positive in 18 cases (14.4%) & negative in 107 cases (85.6%). Two of the positive cases were low grade UC & sixteen were high grade UC. Normal adjacent urothelium was detected in three cases, showing negative GPC3 expression. There was a statistically significant correlation between GPC3 expression and tumor stage. However, no statistically significant correlation detected between GPC3 expression and any of [age, sex, tumor histological subtype, site, gross appearance, size, grade, invasion, multifocality, associated urinary bladder bilharziasis, lymphovascular emboli, perineural invasion & lymph node stage]. Conclusion: GPC3 could be useful in differentiation between low &high grade UC (2/18 & 16/18 respectively). GPC3 may differentiate between neoplastic &non neoplastic urothelial tissue. GPC3 plays a potential role in urothelial carcinogenesis which needs further investigation, for the possibility of therapeutic approach
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Copy number Status Date due Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.27.Ph.D.2018.Sa.G (Browse shelf(Opens below)) Not for loan 01010110076135000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.27.Ph.D.2018.Sa.G (Browse shelf(Opens below)) 76135.CD Not for loan 01020110076135000

Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Pathology

Background: Glypican 3 (GPC3) is an oncofetal protein, playing a role in cell regulation during fetal development, via Wingless/Integration (Wnt) signaling pathway. GPC3 immunohistochemical expression was detected in several tumors, most obvious in hepatocellular carcinoma. GPC3 antibody is under clinical trials for therapeutic approach of hepatocellular carcinoma. Aim of Work: Assessment of immunohistochemical (IHC) expression of GPC3 in urothelial carcinoma (UC), to detect its possible role in stimulating Wnt signaling which is supposed to be partially responsible for urothelial carcinogenesis.Methods: This study consisted of 125 cases of urothelial carcinoma, included 90 cases of radical cystectomies with high grade UC & 35 cases of transurethral resection of bladder tumor (TURT) with low grade UC. IHC was carried out using GPC3 monoclonal antibody. Positive expression was considered when < 10% of tumor cells showed cytoplasmic &/or membranous GPC3 expression, regardless of the intensity. Results: GPC3 expression was positive in 18 cases (14.4%) & negative in 107 cases (85.6%). Two of the positive cases were low grade UC & sixteen were high grade UC. Normal adjacent urothelium was detected in three cases, showing negative GPC3 expression. There was a statistically significant correlation between GPC3 expression and tumor stage. However, no statistically significant correlation detected between GPC3 expression and any of [age, sex, tumor histological subtype, site, gross appearance, size, grade, invasion, multifocality, associated urinary bladder bilharziasis, lymphovascular emboli, perineural invasion & lymph node stage]. Conclusion: GPC3 could be useful in differentiation between low &high grade UC (2/18 & 16/18 respectively). GPC3 may differentiate between neoplastic &non neoplastic urothelial tissue. GPC3 plays a potential role in urothelial carcinogenesis which needs further investigation, for the possibility of therapeutic approach

Issued also as CD

There are no comments on this title.

to post a comment.